DarioHealth Corp. Operating Cash Flow
DarioHealth Corp. (DRIO) reported Operating Cash Flow of -$12.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- DarioHealth Corp. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.08M.
- DarioHealth Corp. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.03M.
- DarioHealth Corp. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.89M.
- DarioHealth Corp. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$7.35M.
- DarioHealth Corp. net cash provided by (used in) operating activities for fiscal 2025 was -$25.94M.
- DarioHealth Corp. net cash provided by (used in) operating activities for fiscal 2024 was -$38.56M.
- DarioHealth Corp. net cash provided by (used in) operating activities for fiscal 2023 was -$30.38M.
- DarioHealth Corp. net cash provided by (used in) operating activities for fiscal 2022 was -$47.84M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 20 month | Net Cash Provided by (Used in) Operating Activities 23 month | Net Cash Provided by (Used in) Operating Activities 26 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$12.11M 10-Q · filed 2026-08-11 | -$18.00M derived: sum of 3 quarters · filed 2026-08-11 | -$25.34M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$6.03M 10-Q · filed 2026-05-13 | -$11.91M derived: sum of 2 quarters · filed 2026-05-13 | -$19.26M derived: sum of 3 quarters · filed 2026-05-13 | -$25.29M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$13.24M derived: sum of 2 quarters · filed 2026-03-19 | -$19.27M derived: sum of 3 quarters · filed 2026-08-11 | -$25.94M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$13.38M derived: sum of 2 quarters · filed 2026-08-11 | -$20.05M 10-Q · filed 2025-11-13 | -$26.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$6.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$12.70M 10-Q · filed 2026-08-11 | -$19.44M derived: sum of 3 quarters · filed 2026-08-11 | -$26.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$6.67M 10-Q · filed 2026-05-13 | -$13.40M derived: sum of 2 quarters · filed 2026-05-13 | -$20.76M derived: sum of 3 quarters · filed 2026-05-13 | -$32.13M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$14.09M derived: sum of 2 quarters · filed 2026-03-19 | -$25.45M derived: sum of 3 quarters · filed 2026-03-19 | -$38.56M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$18.72M derived: sum of 2 quarters · filed 2025-11-13 | -$31.83M 10-Q · filed 2025-11-13 | -$39.17M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$11.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$24.47M 10-Q · filed 2025-08-12 | -$31.81M derived: sum of 3 quarters · filed 2025-08-12 | -$40.46M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$13.11M 10-Q · filed 2025-05-14 | -$20.45M derived: sum of 2 quarters · filed 2025-05-14 | -$29.10M derived: sum of 3 quarters · filed 2025-05-14 | -$38.73M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$15.99M derived: sum of 2 quarters · filed 2025-03-10 | -$25.62M derived: sum of 3 quarters · filed 2025-03-10 | -$30.38M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | -$8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$18.28M derived: sum of 2 quarters · filed 2024-11-07 | -$23.04M 10-Q · filed 2024-11-07 | -$30.98M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$9.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$14.39M 10-Q · filed 2024-08-08 | -$22.33M derived: sum of 3 quarters · filed 2024-08-08 | -$33.03M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$4.76M 10-Q · filed 2024-05-15 | -$12.70M derived: sum of 2 quarters · filed 2024-05-15 | -$23.39M derived: sum of 3 quarters · filed 2024-05-15 | -$34.51M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$18.64M derived: sum of 2 quarters · filed 2024-03-28 | -$29.75M derived: sum of 3 quarters · filed 2024-03-28 | -$47.84M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$21.81M derived: sum of 2 quarters · filed 2023-11-02 | -$39.90M 10-Q · filed 2023-11-02 | -$55.04M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$11.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$29.21M 10-Q · filed 2023-08-10 | -$44.34M derived: sum of 3 quarters · filed 2023-08-10 | -$56.78M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$18.09M 10-Q · filed 2023-05-11 | -$33.23M derived: sum of 2 quarters · filed 2023-05-11 | -$45.66M derived: sum of 3 quarters · filed 2023-05-11 | -$57.97M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$15.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$27.57M derived: sum of 2 quarters · filed 2023-03-09 | -$39.88M derived: sum of 3 quarters · filed 2023-03-09 | -$50.41M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$12.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$24.74M derived: sum of 2 quarters · filed 2022-11-14 | -$35.27M 10-Q · filed 2022-11-14 | -$42.03M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$12.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$22.84M 10-Q · filed 2022-08-15 | -$29.60M derived: sum of 3 quarters · filed 2022-08-15 | -$33.39M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$10.53M 10-Q · filed 2022-05-12 | -$17.29M derived: sum of 2 quarters · filed 2022-05-12 | -$21.08M derived: sum of 3 quarters · filed 2022-05-12 | -$23.72M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$10.55M derived: sum of 2 quarters · filed 2022-03-22 | -$13.19M derived: sum of 3 quarters · filed 2022-03-22 | -$17.74M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | -$3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$6.43M derived: sum of 2 quarters · filed 2021-11-15 | -$10.98M 10-Q · filed 2021-11-15 | -$13.83M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$7.18M 10-Q · filed 2021-08-16 | -$10.04M derived: sum of 3 quarters · filed 2021-08-16 | -$13.42M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$4.54M 10-Q · filed 2021-05-17 | -$7.40M derived: sum of 2 quarters · filed 2021-05-17 | -$10.78M derived: sum of 3 quarters · filed 2021-05-17 | -$16.28M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$6.23M derived: sum of 2 quarters · filed 2021-03-09 | -$11.74M derived: sum of 3 quarters · filed 2021-03-09 | -$15.72M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$8.88M derived: sum of 2 quarters · filed 2020-11-12 | -$12.87M 10-Q · filed 2020-11-12 | -$16.31M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$9.49M 10-Q · filed 2020-08-12 | -$12.93M derived: sum of 3 quarters · filed 2020-08-12 | -$16.17M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$3.99M 10-Q · filed 2020-05-12 | -$3.99M 10-Q · filed 2019-05-13 | -$7.43M derived: sum of 2 quarters · filed 2020-05-12 | -$10.66M derived: sum of 3 quarters · filed 2020-05-12 | -$12.69M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$6.68M derived: sum of 2 quarters · filed 2020-03-17 | -$8.70M derived: sum of 3 quarters · filed 2020-03-17 | -$11.47M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | -$5.26M derived: sum of 2 quarters · filed 2019-10-28 | -$8.03M 10-Q · filed 2019-10-28 | -$10.43M derived: sum of 4 quarters · filed 2019-10-28 | ||||
| 2018-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$4.79M 10-Q · filed 2019-08-13 | -$7.19M derived: sum of 3 quarters · filed 2019-08-13 | -$9.59M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$2.77M 10-Q · filed 2019-05-13 | -$5.16M derived: sum of 2 quarters · filed 2019-05-13 | -$7.56M derived: sum of 3 quarters · filed 2019-05-13 | -$10.30M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$4.79M derived: sum of 2 quarters · filed 2019-03-25 | -$7.54M derived: sum of 3 quarters · filed 2019-03-25 | -$10.62M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$5.14M derived: sum of 2 quarters · filed 2018-11-13 | -$8.22M 10-Q · filed 2018-11-13 | -$10.08M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$5.83M 10-Q · filed 2018-08-09 | -$7.68M derived: sum of 3 quarters · filed 2018-08-09 | -$10.41M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$3.08M 10-Q · filed 2018-05-15 | -$3.08M 10-Q · filed 2018-03-19 | -$4.94M derived: sum of 2 quarters · filed 2018-05-15 | -$7.66M derived: sum of 3 quarters · filed 2018-05-15 | -$9.36M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$4.58M derived: sum of 2 quarters · filed 2018-03-19 | -$6.27M derived: sum of 3 quarters · filed 2018-03-19 | -$8.38M 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | -$4.42M derived: sum of 2 quarters · filed 2018-03-19 | -$6.52M 10-Q · filed 2018-03-19 | |||||
| 2016-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-19 | -$3.80M 10-Q · filed 2018-03-19 | ||||||
| 2016-03-31 | -$2.10M 10-Q · filed 2018-03-19 | |||||||
| 2013-09-30 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$4.50M derived: sum of 2 quarters · filed 2013-11-12 | -$5.47M 10-Q · filed 2013-11-12 | -$8.51M 10-Q · filed 2013-11-12 | ||||
| 2013-06-30 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$3.02M 10-Q · filed 2013-08-14 | -$6.06M 10-Q · filed 2013-08-14 | |||||
| 2013-03-31 | -$971.29K 10-Q · filed 2013-05-14 | -$4.01M 10-Q · filed 2013-05-14 | ||||||
| 2012-09-30 | -$723.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$1.20M derived: sum of 2 quarters · filed 2013-11-12 | -$1.52M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | -$479.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$795.27K 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | -$316.01K 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |